AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error.
"synopsis" may belong to another edition of this title.
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9786208418274
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Seller Inventory # I-9786208418274
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9786208418274
Quantity: Over 20 available
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In. Seller Inventory # ria9786208418274_new
Quantity: Over 20 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. Seller Inventory # 26404115135
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 60 pp. Englisch. Seller Inventory # 9786208418274
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand. Seller Inventory # 409071968
Quantity: 4 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND. Seller Inventory # 18404115125
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9786208418274
Quantity: 1 available
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. Neuware -AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error.Books on Demand GmbH, Überseering 33, 22297 Hamburg 60 pp. Englisch. Seller Inventory # 9786208418274